Results 91 to 100 of about 1,117 (151)

Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort. [PDF]

BMJ Open
Boois L, Ekandjo H, Shavuka O, Nepolo E, Ndong Sima CA, Oelofse C, Uren C, Petersen DC, Möller M, Wijk M, Kellermann T, Decloedt E, McIlleron H, Denti P, Claassens MM.   +14 more
europepmc   +1 more source

Efficacy of regimens targeting Mycobacterium abscessus in vitro and in vivo. [PDF]

BMC Microbiol
Wang Z, Ye Y, Zhang W, Wang B, Chen X, Lu Y.   +5 more
europepmc   +1 more source

Single-Mitochondrion ATP Profiling Directs Discovery of Targetable OXPHOS Dependency in Cancers. [PDF]

Adv Sci (Weinh)
Xiao X, Lu C, Chen H, Zhou J, Hu Y, Di H, Su G, Yan X.   +7 more
europepmc   +1 more source

Transmission of bedaquiline-resistant Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. [PDF]

Am J Respir Crit Care Med
Sobol R, Omar SV, Brown TS, Joseph L, Lutchminarian K, Tang L, Lan Y, Willis F, Campbell A, Warren JL, Cohen T, Brust JCM, Naidoo K, Shah NS, Gandhi NR, Mathema B, CONTEXT Study Team.   +16 more
europepmc   +1 more source

Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study. [PDF]

Clin Infect Dis
Singla R, Khan S, Silsarma A, Chavan V, Mahajan R, Mansoor H, Devan RK, Singla N, Bhalla M, Kumar G, Singh P, Iyer A, Morales M, Devkota SC, Dalal A, Spencer H, Isaakidis P.   +16 more
europepmc   +1 more source

Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice. [PDF]

J Infect Dis
Lee BY, Clemens DL, Masleša-Galic S, Nava S, Lo CY, Zink JI, Horwitz MA.   +6 more
europepmc   +1 more source

Bedaquiline does not enhance a clofazimine-azithromycin-ethambutol regimen against <i>Mycobacterium avium</i> in the hollow-fiber system. [PDF]

Antimicrob Agents Chemother
Raaijmakers J, Salillas S, Aarnoutse R, Svensson E, Te Brake L, Stemkens R, Wertheim H, Hoefsloot W, van Ingen J.   +8 more
europepmc   +1 more source

Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysis. [PDF]

BMC Infect Dis
Guzman KJ, Wolf A, Perumal R, Lu X, Boodhram R, Seepamore B, Reis K, Amico KR, Friedland G, Zelnick JR, Daftary A, Cummings M, Padayatchi N, Naidoo K, O'Donnell M.   +14 more
europepmc   +1 more source

Sub-MIC levels of bedaquiline and clofazimine can select <i>Mycobacterium tuberculosis</i> mutants with increased MIC. [PDF]

Antimicrob Agents Chemother
Villellas C, Stevenaert F, Remmerie B, Andries K.   +3 more
europepmc   +1 more source

Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TB. [PDF]

Indian J Med Res
Muniyandi M, Nagarajan K, Chelvanayagam K, Rajsekar K, Tyagi K, Padmapriyadarsini C.   +5 more
europepmc   +1 more source